News
Portfolio Company News
- June 25, 2008
Immune Design Gets $18M for Vaccines and Adjuvants
- June 17, 2008
Intradigm Announces Allowance of Key RNA
Interferance (RNAi) Patent
- June 10, 2008
Astex Strikes $500M Deal for its Fibroblast Receptor - June 10, 2008
ChemGenex Acquires Full Control of Omacetaxine
- June 05, 2008
Anesiva and Transcription Factor Sign Licensing Agreement
- May 22, 2008
U3 Pharma Sale Boosts German Biotech Market - May 22, 2008
U3 - Daiichi Sankyo to Purchase German Biotech for $235M
- May 19, 2008
Cerenis Therapeutics Completes Successful Phase I Clinical Trial Of Cer-002
- May 12, 2008
USGI Medical Licenses Incisionless Surgery Technology to Intuitive Surgical
- May 02, 2008
OPAL - New Immune Treatment May Control AIDS Virus
- May 01, 2008
For Lipitor King, It’s Deja Vu All Over Again - Esperion Therapeutics
- May 01, 2008
Esperion Therapeutics Completes $22.75 M Series A Financing
- April 28, 2008
SurgRx Seals Up $20M Series G - April 23, 2008
Aegis Lightwave Acquires CardinalPoint Optics
- April 21, 2008
Investors Remain Cautious - April 16, 2008
BioWorld AACR Roundup - ChemGenex - April 15, 2008
Kiadis Pharma receives Orphan Drug Designation for Rhitol™ from the FDA
- April 11, 2008
ATS Medical Announces First North American Commercial Implant of the ATS 3f Aortic Bioprosthesis
- April 08, 2008
USGI - New Incisionless Procedure Performed to Treat Weight Regain After Gastric Bypass
- April 08, 2008
LifeCycle Pharma - Major Shareholder Exercises Significant Number of Preemptive Rights
< Previous
